Mitsubishi UFJ Trust & Banking Corp Decreases Holdings in CME Group Inc. (NASDAQ:CME)

Mitsubishi UFJ Trust & Banking Corp decreased its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 1.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 287,920 shares of the financial services provider’s stock after selling 3,135 shares during the period. Mitsubishi UFJ Trust & Banking Corp owned 0.08% of CME Group worth $57,647,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Capital Advisors Ltd. LLC raised its holdings in shares of CME Group by 5.0% in the third quarter. Capital Advisors Ltd. LLC now owns 1,032 shares of the financial services provider’s stock worth $207,000 after buying an additional 49 shares during the last quarter. West Family Investments Inc. raised its holdings in shares of CME Group by 3.4% in the second quarter. West Family Investments Inc. now owns 1,503 shares of the financial services provider’s stock worth $278,000 after buying an additional 50 shares during the last quarter. Glassman Wealth Services raised its holdings in shares of CME Group by 11.6% during the second quarter. Glassman Wealth Services now owns 502 shares of the financial services provider’s stock worth $93,000 after purchasing an additional 52 shares during the last quarter. Fidelis Capital Partners LLC raised its holdings in shares of CME Group by 3.9% during the third quarter. Fidelis Capital Partners LLC now owns 1,400 shares of the financial services provider’s stock worth $280,000 after purchasing an additional 52 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its holdings in shares of CME Group by 0.3% during the second quarter. Thrivent Financial for Lutherans now owns 15,841 shares of the financial services provider’s stock worth $3,243,000 after purchasing an additional 52 shares during the last quarter. Hedge funds and other institutional investors own 85.69% of the company’s stock.

Insider Activity at CME Group

In other CME Group news, Director Bryan T. Durkin sold 5,560 shares of the business’s stock in a transaction that occurred on Monday, December 11th. The shares were sold at an average price of $216.37, for a total transaction of $1,203,017.20. Following the completion of the transaction, the director now owns 62,452 shares in the company, valued at approximately $13,512,739.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Derek Sammann sold 10,681 shares of the company’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $220.50, for a total value of $2,355,160.50. Following the completion of the transaction, the insider now owns 1,862 shares in the company, valued at approximately $410,571. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 5,560 shares of the company’s stock in a transaction on Monday, December 11th. The shares were sold at an average price of $216.37, for a total transaction of $1,203,017.20. Following the completion of the transaction, the director now owns 62,452 shares of the company’s stock, valued at approximately $13,512,739.24. The disclosure for this sale can be found here. Over the last quarter, insiders sold 18,103 shares of company stock worth $3,971,672. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on CME shares. Morgan Stanley raised their target price on shares of CME Group from $215.00 to $220.00 and gave the stock an “equal weight” rating in a report on Thursday, October 26th. The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a research report on Wednesday, January 3rd. Barclays lowered shares of CME Group from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $244.00 to $222.00 in a research report on Monday, January 8th. Finally, Rosenblatt Securities restated a “sell” rating and set a $180.00 price target on shares of CME Group in a research report on Thursday, January 4th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $213.89.

Get Our Latest Stock Report on CME

CME Group Trading Up 0.5 %

Shares of CME stock opened at $205.09 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03. The stock has a market capitalization of $73.83 billion, a P/E ratio of 24.47, a price-to-earnings-growth ratio of 2.36 and a beta of 0.48. The company has a 50 day moving average price of $207.00 and a 200 day moving average price of $207.74. CME Group Inc. has a fifty-two week low of $174.01 and a fifty-two week high of $223.80.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 26th. Investors of record on Friday, March 8th will be issued a $1.15 dividend. The ex-dividend date is Thursday, March 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.24%. This is a boost from CME Group’s previous quarterly dividend of $1.10. CME Group’s payout ratio is 52.51%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.